Home Resources eBooks Cell Therapy Today…New Developments in Immunotherapy Cell Therapy Today…New Developments in Immunotherapy December 6, 2018 View eBook Sponsored by: PHC Corporation, Biomedical Division AnatomyBioprocessingCell therapyCellsCellular, Molecular and Developmental BiologyDNADrugsGenetic Engineering and BiotechnologyImmunotherapyMedicine, Diagnosis, and TherapeuticsMolecular biologyNucleic acidsPharmacologyTherapeutics Previous articleThe Netherlands Ups Its Biopharma GameNext articleMicrobiome Modeling Reveals How Bacteria Shape Host Fitness Also of Interest T-Cell Therapy in Solid Tumors May Be Improved by Enzyme Syngene Expects Its New Biologics Manufacturing Facility in India to Be Operational from Mid-Year New DNA Origami Platform, DoriVac, Opens New Path for Designer Cancer Vaccine Development 10x Ships First Single Cell GEM-X Assays to Customers StockWatch: Blockbuster Sales Projected for Madrigal MASH Drug Machine Learning Can Spot Tumor-Reactive TCRs, Speed Immunotherapies Related Media Bioprocessing in Beantown: GEN Reports Live from Day 2 at BPI Excitement in Oakland: A Report from SynBioBeta BIO CEO Rachel King Outlines Industry's Challenges on "Close to the Edge" Carl Icahn States His Case for Change at Illumina on "Close to the Edge" Celebrating DNA Day: An Interview with Eric Green on "The State of Genomics" Celebrating DNA: Matthew Cobb's Reflections on the Double Helix Related Content T-Cell Therapy in Solid Tumors May Be Improved by Enzyme Syngene Expects Its New Biologics Manufacturing Facility in India to Be Operational from Mid-Year New DNA Origami Platform, DoriVac, Opens New Path for Designer Cancer Vaccine Development 10x Ships First Single Cell GEM-X Assays to Customers